Your browser doesn't support javascript.
loading
Pioglitazone Synthetic Analogue Ameliorates Streptozotocin-Induced Diabetes Mellitus through Modulation of ACE 2/Angiotensin 1-7 via PI3K/AKT/mTOR Signaling Pathway.
Ahmed, Yasmin M; Abdelgawad, Mohamed A; Shalaby, Khaled; Ghoneim, Mohammed M; AboulMagd, Asmaa M; Abdelwahab, Nada S; Hassan, Hossam M; Othman, Asmaa M.
Affiliation
  • Ahmed YM; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Nahda University, Beni-Suef 62514, Egypt.
  • Abdelgawad MA; Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka 72341, Al Jouf, Saudi Arabia.
  • Shalaby K; Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka 72341, Al Jouf, Saudi Arabia.
  • Ghoneim MM; Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Ad Diriyah 13713, Saudi Arabia.
  • AboulMagd AM; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Nahda University, Beni-Suef 62514, Egypt.
  • Abdelwahab NS; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Nahda University, Beni-Suef 62514, Egypt.
  • Hassan HM; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62521, Egypt.
  • Othman AM; Department of Pharmacognosy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62521, Egypt.
Pharmaceuticals (Basel) ; 15(3)2022 Mar 10.
Article in En | MEDLINE | ID: mdl-35337139

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Year: 2022 Type: Article